Screener
Cytek Biosciences, Inc. CTKB Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s free cash flow?
- Cytek Biosciences, Inc. (CTKB) reported free cash flow of -$849K in Q2 2026.
- How has Cytek Biosciences, Inc.'s free cash flow changed year-over-year?
- Cytek Biosciences, Inc.'s free cash flow increased by 42.2% year-over-year, from -$1.47M to -$849K.
- What is the long-term trend for Cytek Biosciences, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s free cash flow has grown at a 139.6% compound annual growth rate (CAGR), from $266K to -$8.77M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Cytek Biosciences, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude